Evidence map›Paper›PMID 27016366›Full record

ArticleMedical & biological engineering & computing2016

Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome.

Francesc Miralles

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Lambert-Eaton Myasthenic syndrome: early diagnosis is key.Degenerative neurological and neuromuscular disease · 2019
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Francesc MirallesUnitat de Patologia Neuromuscular, Servei de Neurologia, Hospital Universitari Son Espases, Carretera de Valldemossa, 79, 07010, Palma De Mallorca, Illes Balears, Spain. francesc.miralles@ssib.es.
Hospital Universitario Son Espases · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myasthenia gravis (MG) is an autoimmune postsynaptic disorder of neuromuscular transmission caused, in most patients, by antibodies against postsynaptic acetylcholine receptors. Lambert-Eaton myasthenic syndrome (LEMS) is a presynaptic autoimmune disease in which there is a reduction in Ca

Indexed as

Electric Stimulation TherapyModels, NeurologicalAction PotentialsAlgorithmsCalciumComputer SimulationHumansLambert-Eaton Myasthenic SyndromeMyasthenia GravisNerve TissueNeuromuscular JunctionProbabilitySynaptic TransmissionTime FactorsCalciumComputer simulationElectromyographyLambert–Eaton myasthenic syndromeMyasthenia gravisSynaptic transmission

Identifiers

PMID27016366
OpenAlexW2303992924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.